Patents by Inventor Briggs W. Morrison

Briggs W. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
    Publication number: 20230035183
    Abstract: The present invention relates to methods of treating sclerotic conditions and more specifically to methods of treating chronic graft versus host disease with specific dosages of an anti-CSF-1R antibody, specifically axatilimab.
    Type: Application
    Filed: December 9, 2020
    Publication date: February 2, 2023
    Inventors: Peter ORDENTLICH, Michael MEYERS, Briggs W. MORRISON
  • Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
    Patent number: 6486204
    Abstract: A COX-2 selective inhibiting drug is disclosed as useful in treating or preventing prostate cancer. The compound is used alone or in combination with other drugs.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: November 26, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Joanne Waldstreicher, Briggs W. Morrison
  • Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
    Publication number: 20010047022
    Abstract: A COX-2 selective inhibiting drug is disclosed as useful in treating or preventing prostate cancer. The compound is used alone or in combination with other drugs.
    Type: Application
    Filed: January 26, 2001
    Publication date: November 29, 2001
    Inventors: Joanne Waldstreicher, Briggs W. Morrison
  • Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
    Publication number: 20010041713
    Abstract: A COX-2 selective inhibiting drug is disclosed as useful in treating or preventing prostate cancer. The compound is used alone or in combination with other drugs.
    Type: Application
    Filed: February 16, 2001
    Publication date: November 15, 2001
    Inventors: Joanne Waldstreicher, Briggs W. Morrison
  • DNA encoding Mat-8
    Patent number: 5728579
    Abstract: A novel chloride channel protein found in human breast cancer cells is disclosed. The chloride channel protein, called Mat-8, serves as a useful diagnostic reagent for the detection of breast cancer. The Mat-8 protein and chloride channel proteins generally, are useful therapeutic targets for the treatment of breast cancer.
    Type: Grant
    Filed: August 11, 1994
    Date of Patent: March 17, 1998
    Assignees: President and Fellows of Harvard College, The General Hospital Corporation
    Inventors: Briggs W. Morrison, Philip Leder